ClinicalTrials.gg
RecruitingNCT05048680HYPOXAGEUpdated May 8, 2026

Effect of Hypoxic Conditioning on Cerebrovascular Health in the Elderly

An interventional study of Hypoxia and/or Exercise in Hypoxia, Cerebral Hypoxia and Brain Diseases, sponsored by University Hospital, Grenoble. Recruiting at 1 site in France. Open to participants aged 60 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-08.

Primary conditionHypoxia, BrainRegistry: HypoxiaReclassifiedWhy we changed it
Registry
Hypoxia — the first condition term the registry derived for this study.
ClinicalTrials.gg
Hypoxia, Brain
Why
  1. The study's listed conditions name Hypoxia, Brain, a narrower term within Hypoxia.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University Hospital, Grenoble · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Oct 2021; still recruiting 5 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
60 Years to 80 Years
Sex
All
01

Study summary

In line with the ever-growing aging of Western populations, the development of preventive strategies to slow down the effects of aging on cardiovascular health represents a major challenge in order to preserve functional capacities and a sufficient quality of life in the elderly. The alteration of vascular function (at the cerebral and systemic level) with aging is an important feature in the clinical picture including a decrease in physical and cognitive capacities. Although physical activity is recognized as an essential means of combating the effects of aging, optimizing its effects by defining the most effective strategies of practice remains a key objective. Offering alternative interventions to exercise training is also necessary for people who are unwilling or unable to engage in a physical activity program. In this context, hypoxic conditioning, alone or in conjunction with rehabilitative exercise training, is a new therapeutic modality with strong preclinical validity, in particular from a cardiovascular standpoint, and used in other pathologies to improve cardiovascular function and exercise performance and quality of life. Our aim is, therefore, to investigate the effect of hypoxic conditioning (alone or in conjunction with exercise training) on cerebrovascular health in the elderly.

02

Conditions studied

  • Hypoxia
  • Cerebral Hypoxia
  • Brain Diseases
  • Exercise
  • Aging
  • Cognitive Decline
  • Healthy Aging
03

In context

Hypoxia, Brain Reclassified

81 studies on the registry are indexed under Hypoxia, Brain; 19 are open to participants now.

This study's planned enrollment of 64 is close to the median of 60 across 55 interventional studies indexed under Hypoxia, Brain.

Browse Hypoxia, Brain studies →

Lead sponsor

University Hospital, Grenoble is the lead sponsor of 837 studies on the registry; 207 are open to participants now.

Compared within Hypoxia, Brain, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Hypoxia. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
60 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 60 to 80 years of age;
  • Being physically inactive (less than 150 min/week of moderate to intense physical activity);
  • No chronic cardiovascular, respiratory, metabolic or neuromuscular disease counterindicating an exercise training or hypoxic conditioning program;
  • Health coverage;
  • Being able to provide written fully .

Exclusion criteria

Exclusion Criteria:

  • Body-mass index >30 kg/m2;
  • Smoking (> cigarettes/day);
  • Alcohol use (> 10g/day);
  • Mental disorder or history of mental disorder;
  • Beta-blockade treatment;
  • Inability or refusal to provide ;
  • No health coverage
  • People exceeding the annual ceiling of allowances received as a result of their participation in other clinical trials;
  • People deprived of freedom by judicial or administrative decision;
  • People subject to legal protection, who cannot be included in clinical trials.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    Hypoxia - Rest

    Sessions of intermittent hypoxia at rest; 3 sessions/week; 8 weeks. To be compared with the placebo (normoxia) group at rest.

    Procedure: Hypoxia and/or Exercise

  • Placebo comparator
    Normoxia - Rest

    Sessions of normoxia at rest; 3 sessions/week; 8 weeks.

    Procedure: Hypoxia and/or Exercise

  • Experimental
    Hypoxia - Exercise

    Sessions of exercise training under hypoxia; 3 sessions/week; 8 weeks. To be compared with the placebo (exercise under normoxia) group.

    Procedure: Hypoxia and/or Exercise

  • Active comparator
    Normoxia - Exercise

    Sessions of exercise training under hypoxia; 3 sessions/week; 8 weeks.

    Procedure: Hypoxia and/or Exercise

Interventions

  • ProcedureHypoxia and/or Exercise

    Hypoxia at rest versus normoxia at rest; Hypoxia during exercise versus Normoxia during exercise.

06

What researchers measure

Primary outcomes

  1. Middle cerebral artery flow velocity

    Changes in middle cerebral artery flow velocity in response to hypercapnia (5% CO2)

    Time frame: Before intervention; right after intervention; 2 months after intervention

Secondary outcomes

  1. Peak oxygen uptake

    Peak oxygen uptake during a cardiopulmonary exercise test

    Time frame: Before intervention; right after intervention; 2 months after intervention

  2. Flow-mediated dilation

    Flow-mediated dilation in response to ischemia-reperfusion of the brachial artery

    Time frame: Before intervention; right after intervention; 2 months after intervention

  3. Blood pressure

    24h (systolic, diastolic and mean) blood pressure assessment

    Time frame: Before intervention; right after intervention; 2 months after intervention

  4. Sleep

    Sleep features assessed by polygraphy

    Time frame: Before intervention; right after intervention; 2 months after intervention

  5. Cognitive function

    Cognitive function assessed by the Montreal Cognitive Assessment questionnaire

    Time frame: Before intervention; right after intervention; 2 months after intervention

  6. Health-related quality of life

    Health-related quality of life assessed by the SF-36 questionnaire

    Time frame: Before intervention; right after intervention; 2 months after intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — No plan at this point in time.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05048680
Responsible party
Sponsor
First posted
Sep 17, 2021
Start date
Oct 13, 2021
Primary completion
Mar 17, 2024
Completion
Sep 2026 (estimated)
Last update
May 8, 2026

Study contacts

Stéphane Doutreleau, MD, PhD
Contact
sdoutreleau@chu-grenoble.fr
+33476767773
Samuel Vergès, PhD
Contact
sverges@chu-grenoble.fr
+33476766860
Stéphane Doutreleau, MD, PhD
principal investigator · CHU Grenoble Alpes, Grenoble Alpes University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion